Frontiers in Oncology | Cancer Immunity and Immunotherapy

Case Report

Published on 24 Dec 2024

Neoadjuvant immunotherapy plus chemotherapy for squamous cell carcinoma of the paranasal sinus: a case report

in Cancer Immunity and Immunotherapy

Ying Sun
Guanghui Yang
Ruijie Sun
Fangli Cao

Frontiers in Oncology

doi 10.3389/fonc.2024.1462993

762 views
1 citation

Case Report

Published on 24 Dec 2024

Case report: Aggressive NSCLC with partial BRG-1 deficiency and KRAS G12C mutation: a case study and treatment challenges

in Cancer Immunity and Immunotherapy

Chengwei Jin
Hong Ge
Dongsheng Hou
Jing Li
Mingming Tan

Frontiers in Oncology

doi 10.3389/fonc.2024.1515240

1,097 views

Systematic Review

Published on 23 Dec 2024

Prognostic significance of systemic immune inflammation index in patients with urothelial carcinoma: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Lei Zheng
Zuoping Wang
Yunxiang Li
Si Ge
Zhiqiang Zeng
Lijian Gan
Chunyang Meng
Kangsen Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1469444

727 views

Review

Published on 20 Dec 2024

10 years of BiTE immunotherapy: an overview with a focus on pancreatic cancer

in Cancer Immunity and Immunotherapy

Solange R. Paredes-Moscosso
Amit C. Nathwani

Frontiers in Oncology

doi 10.3389/fonc.2024.1429330

2,085 views
1 citation

Case Report

Published on 20 Dec 2024

Successful treatment of recurrent refractory Kaposi’s sarcoma in AIDS: a case report

in Cancer Immunity and Immunotherapy

Feng Li
Rongrong Zheng
Jun Yan
Zhongdong Zhang
Hong Liu
Jinchuan Shi

Frontiers in Oncology

doi 10.3389/fonc.2024.1462381

786 views

Original Research

Published on 19 Dec 2024

Gut virome dysbiosis impairs antitumor immunity and reduces 5-fluorouracil treatment efficacy for colorectal cancer

in Cancer Immunity and Immunotherapy

Hui Huang
Ying Yang
Xiaojiao Wang
Biao Wen
Xianglan Yang
Wei Zhong
Qiurong Wang
Feng He
Jun Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1501981

959 views

Original Research

Published on 17 Dec 2024

Cost-effectiveness analysis of anlotinib plus chemotherapy with or without benmelstobart versus chemotherapy alone for extensive-stage small-cell lung cancer in China

in Cancer Immunity and Immunotherapy

Caicong You
Jiahao Zhang
Jianying Lei
Wu Fu
Bin Zheng
Maobai Liu
Na Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1484650

930 views

Original Research

Published on 17 Dec 2024

The establishment of PD-1 inhibitor treatment prognosis model based on dynamic changes of peripheral blood indexes in patients with advanced lung squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Yuyan Xie
Hao Sun
Liying Shan
Xin Ma
Qingyu Sun
Fang Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1454709

838 views

Systematic Review

Published on 12 Dec 2024

Efficacy and safety of immune checkpoint inhibitors rechallenge in advanced solid tumors: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Jiahui Cao
Xinyao Ding
Jianan Ji
Lin Zhang
Chengyan Luo

Frontiers in Oncology

doi 10.3389/fonc.2024.1475502

1,377 views

General Commentary

Published on 12 Dec 2024

General commentary: GQIcombi application to subdue glioma via differentiation therapy

in Cancer Immunity and Immunotherapy

BinBin Yuan
Hui Gong

Frontiers in Oncology

doi 10.3389/fonc.2024.1466102

505 views

Systematic Review

Published on 11 Dec 2024

Efficacy and safety of first-line immunotherapy-containing regimens compared with chemotherapy for advanced or metastatic urothelial carcinoma: a network meta-analysis of randomized controlled trials

in Cancer Immunity and Immunotherapy

Weiming Liang
Shibo Huang
Yanping Huang
Miaoyan Huang
Chunyan Li
Yiwen Liang
Li Pang

Frontiers in Oncology

doi 10.3389/fonc.2024.1453338

1,093 views

Original Research

Published on 05 Dec 2024

Association of the SNPs in CCL2 and CXCL12 genes with the susceptibility to breast cancer: a case-control study in China

in Cancer Immunity and Immunotherapy

Duanchong Zhao
Xingxing Yu
Hongli Huang
Shuqing Zou
Pingxiu Zhu
Yuxiang Lin
Mengjie Song
Fangmeng Fu
Haomin Yang

Frontiers in Oncology

doi 10.3389/fonc.2024.1475979

845 views

Review

Published on 02 Dec 2024

Progress of research on PD-L1 inhibitor adebrelimab usage in malignant tumors

in Cancer Immunity and Immunotherapy

Pan Cheng
Jichen He
Pingping Cheng
Kaixia Chen
Guangyu Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1468569

1,029 views

Correction

Published on 02 Dec 2024

Corrigendum: Case report: A sustained survival benefit of third-line immunotherapy for refractory thymic carcinoma

in Cancer Immunity and Immunotherapy

Mi Meng
Bo Yu
Jie Luo
Yuju Bai
Lin Li
Shicheng Chen
Sisi He
Hu Ma

Frontiers in Oncology

doi 10.3389/fonc.2024.1516024

352 views

Case Report

Published on 27 Nov 2024

Abscopal effect-induced spontaneous regression of distant metastases in malignant mesenchymal tumor: a case report

in Cancer Immunity and Immunotherapy

Meltem Kirli Bolukbas
Cemile Ozdemir
Esengul Kocak Uzel

Frontiers in Oncology

doi 10.3389/fonc.2024.1475129

528 views

Case Report

Published on 26 Nov 2024

Refractory hypokalemia and metabolic acidosis induced by undifferentiated connective tissue disease secondary to immune checkpoint inhibitors: a case report and literature review

in Cancer Immunity and Immunotherapy

Yinfang Gu
Lilan Yi
Xiaofang Zou
Longhua Guo
Guowu Wu
Jingjing Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1442605

986 views
1 citation